Prolactin alters the mechanisms of B cell tolerance induction.

Objective: Autoimmune diseases predominantly affect women, suggesting that female sex hormones may play a role in the pathogenesis of such diseases. We have previously shown that persistent mild-to-moderate elevations in serum prolactin levels induce a break in self tolerance in mice with a BALB/c genetic background. The aim of this study was to evaluate the effects of hyperprolactinemia on the mechanisms of B cell tolerance induction.

Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?

The lactogenic hormone prolactin is produced in part by cells of the immune system and serves as an upregulator of immune function. Hyperprolactinemia is common in patients with systemic lupus erythematosus (SLE), raising the possibility that the hormone contributes to the excessive immune response in the disease. The highest levels of circulating prolactin occur in association with prolactin-secreting tumors, but prolactinomas have only rarely been encountered in patients with SLE.

Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection.

We describe 8 patients who presented with fever, weight loss, anemia, and oral and/or esophageal candidiasis, and who were initially thought to have human immunodeficiency virus (HIV) infection or lymphoma. These patients fulfilled American College of Rheumatology criteria for systemic lupus erythematosus (SLE) because of arthralgias or arthritis, hematological derangements, and immunological abnormalities. Treatment was delayed because SLE did not immediately enter into the differential diagnosis.

Relapsing arterial aneurysms in juvenile Behçet's disease.

Vascular involvement in Behçet's disease has a wide range of clinical manifestations, the most common being thrombophlebitis and arterial aneurysms. Every major vessel may be involved, but aneurysms of the carotid artery are relatively rare in adults and even rarer in children. We describe here a case of a 13-year-old boy with Behçet's disease with a recurrent carotid artery aneurysm treated with arterial ligation and immunosuppressive therapy who later developed an abdominal aortic aneurysm in the absence of other indications of disease activity.